Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$1.92 - $4.39 $33,152 - $75,802
-17,267 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$2.41 - $4.4 $41,613 - $75,974
17,267 New
17,267 $70,000
Q2 2019

Aug 14, 2019

SELL
$2.53 - $3.04 $41,112 - $49,400
-16,250 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$2.51 - $3.73 $40,787 - $60,612
16,250 New
16,250 $48,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.